4//SEC Filing
Foundation Medicine, Inc. 4
Accession 0001209191-16-153308
CIK 0001488613operating
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 4:02 PM ET
Size
6.1 KB
Accession
0001209191-16-153308
Insider Transaction Report
Form 4
Daly David
Chief Commercial Officer
Transactions
- Sale
Common Stock
2016-12-01$19.95/sh−564$11,252→ 106,290 total
Footnotes (3)
- [F1]Represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of restricted stock units on November 30, 2016. This sale is mandated by the Issuer's election under its equity incentive plans to require the reporting person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the reporting person.
- [F2]The price reported in this Column 4 is a weighted average price. The shares were sold as part of a group sale of shares in multiple transactions at prices ranging from $19.91 to $19.95, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
- [F3]The reporting person previously reported the restricted stock units granted to the reporting person on December 5, 2014 in Table I of the Form 4 filed on December 9, 2014. As such, no adjustment to the reporting persons beneficial interest needs to be made to reflect the vesting event related to this securities sale.
Documents
Issuer
Foundation Medicine, Inc.
CIK 0001488613
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001488613
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 4:02 PM ET
- Size
- 6.1 KB